抄来的, 给闲云看看.
The retinoblastoma tumor suppressor protein, Rb, regulates cell proliferation by controlling progression through the restriction point within the G1-phase of the cell cycle (1). Rb has three functionally distinct binding domains and interacts with critical regulatory proteins including the E2F family of transcription factors, c-Abl tyrosine kinase and proteins with a conserved LXCXE motif (2-4). Cell cycle-dependent phosphorylation by a CDK inhibits Rb target binding and allows cell cycle progression (5). Rb inactivation and subsequent cell cycle progression likely requires an initial phosphorylation by cyclin D-CDK4/6 followed by cyclin E-CDK2 phosphorylation (6). Specificity of different CDK/cyclin complexes has been observed in vitro (6-8) and cyclin D1 is required for Ser780 phosphorylation in vivo (9).
1. Sherr, C.J. (1996) Science 274, 1672-1677.
2. Nevins, J.R. et al. (1992) Science 258, 424-429.
3. Welch, P.J. and Wang, J.Y. (1993) Cell 75, 779-790.
4. Hu, Q.J. et al. (1990) EMBO J. 9, 1147-1155.
5. Knudsen, E.S. and Wang, J.Y. (1997) Mol. Cell. Biol. 17, 5771-5783.
6. Lundberg, A.S. and Weinberg, R.A. (1998) Mol. Cell. Biol. 18, 753-761.
7. Connell-Crowley, L. et al. (1997) Mol. Cell. Biol. 8, 287-301.
8. Kitagawa, M. et al. (1996) EMBO J. 15, 7060-7069.
9. Geng, Y. et al. (2001) Proc. Natl. Acad. Sci. USA 98, 194-199.
